New NICE position on lenalidomide

NICE has issued final draft guidance recommending lenalidomide as an option for treating myelodysplastic syndromes.

Source: Pharmacy Europe - August 20, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Haematology celgene Latest News lenalidomide myelodysplastic syndromes nice revlimid Source Type: news